COMPANY INFORMATION
History
The company was founded in 2005 and has laboratories and offices in Research Triangle Park, North Carolina.
Strategy
The Company strategy is to use its broad product and technology platform to develop a portfolio of botanical prescription drugs, while simultaneously generating revenues and licensing fees from other value-added sources (see Partnerships). PhytoPharmacon has identified a number of drug candidates in oncology, cardiovascular disease, and the anti-inflammatory field including asthma. By selecting drug candidates whose efficacy and safety have already been established over hundreds of years in China, India, USA and Europe, PhytoPharmacon expects to be able to reduce the time taken to bring these proprietary botanical drugs to market.
Management
The Company management has extensive experience in all aspects of the development and commercialization of pharmaceutical and biological products.
|
 Dr. Subbiah is Founder/President, and CSO of PhytoMyco Research Corporation, Greenville, NC; Founder/Chairman, of PhytoMyco Res. Pvt. Ltd. Mysore, India. He worked as Principal Investigator at RJR-Nabisco and was Senior Research Scientist at OSI Pharmaceuticals, Uniondale, NY, USA. Dr. Subbiah has published 80 papers, and has10 issued patents and 20 patents pending.
|
|
|
 Dr. Dev received his degree from UNC, Chapel Hill and has more than 35 years of experience in pharmaceutical drug discovery working for GlaxoSmithKline in the areas of anticancer, antimicrobial and antiviral therapeutics. He has published 65 scientific papers and has 13 patents issued and pending.
|
|
|
 Dr. Cipau, a partner with Key Healthcare Partners, is a seasoned pharmaceutical executive and chemical engineer. He was President and CEO of Nippon Wellcome KK, Copley Pharmaceuticals, Catalytica Pharmaceuticals and Biolex. He is a member of the Board of Directors for ENS Inc. and Bob Barker Co.
|
|
Advisors
Amy DelaCourt Cipau, MBA, Marketing and Business Development Advisor.
Amy, a partner with Key Healthcare Partners, was past Vice President Pharmaceutical Marketing and Sales for Catalytica Pharmaceuticals Inc. and Director of Marketing and Commercial Strategy for Medco Research Inc. and Copley Pharmaceuticals. She was Senior Product Manager at Burroughs Wellcome for several major brands.
- Dr. Irving G. Joshua, Professor and Chair, University of Louisville, KY, Pre-clinical advisor.
- Fred Hutchison, Hutchison Law Group PLLC, Corporate counsel.
- Jim Passe, Passé Intellectual Property, LLC, IP counsel.
|
